UPDATE: Barclays Downgrades Bristol-Myers, Cuts Price Target By 41%

By: via Benzinga
Shares of Bristol-Myers Squibb (NYSE: BMY) are trading lower after Barclays cut the company from Overweight to Equal-weight and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.